PureTech Health (GB:PRTC) has released an update.
PureTech Health, a clinical-stage biotherapeutics company, will release its half-yearly financial results on August 28, 2024. Investors and analysts can look forward to a presentation and conference call on the same day. The company, known for its extensive pipeline of 29 therapeutic candidates, continues to advance its clinical development programs, including a potential new FDA-approved treatment.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
